The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Share News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Yourgene surges on takeover by Novacyt

Mon, 03rd Jul 2023 10:48

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

----------

AIM - WINNERS

----------

Yourgene Health PLC, more than doubled to 0.47 pence from 0.20p at Friday's market close, 12-month range 0.12p-8.00p. Shares in the medical diagnostics company rocket as it agrees to a takeover offer from Novacyt SA at 0.522 pence per share in cash. The deal values Yourgene's equity at GBP16.7 million. The companies say the acquisition "strongly aligns" with Novacyt's post-Covid strategy, which included pursuing strategic mergers and acquisitions to support its long-term growth and prioritised the twin objectives of geographic expansion and portfolio development. Shares in Novacyt, a fellow AIM listing, jump 24%.

----------

Verici Dx PLC, up 11% at 13.0p, 12-month range 4.53p-19p. The Cardiff, Wales-based developer of clinical diagnostics for organ transplants receives successful results from its clinical study of Clarava that demonstrate it as a test capable of informing a clear, actionable response from clinicians. Clarava is the company's pre-transplant prognostic test to allow measurement of a patient's immune response to assess the risk of early kidney graft rejection, which could assist an estimated 65,000 patients. Verici Dx says it is on track to launch Clarava commercially in the US before the end of 2023.

----------

AIM - LOSERS

----------

Zanaga Iron Ore Co Ltd, down 22% at 9.75p, 12-month range 1.7p-18.9p. The iron explorer focused on the Republic of the Congo enters into an equity subscription agreement with institutional investor Shard Merchant Capital Ltd. Zanaga will issue up to 36 million shares in up to three tranches of 12 million each. At the current price, the shares will be worth GBP3.7 million in total. Also on Monday, Zanaga reports it swung to a pretax profit in 2022 of USD8.1 million from a loss of USD1.9 million the year before. It generated no revenue, unchanged from a year prior, but reports a USD9.1 million gain on the revaluation of investment.

----------

Kibo Energy PLC, down 12% at 0.05p, 12-month range 0.05p-0.22p. The energy projects in Africa and UK says all funding activities, including the company's proposed AIM-listed vehicle Ultimate Sustainable Energy, have been placed on hold due to delays as a result of "difficulties" at its extraordinary general meeting. Early last month, Kibo reported that five of a total of eight resolutions failed to reach the minimum threshold of 75% of the vote at an EGM. These include equity securities allotment, amendment of the Memorandum of Association and amendment of the Articles of Association. It said back then that 35% of shareholders voted against these resolutions. On Thursday last week, Kibo said it sought funding to address a liquidity crunch. It said liquidity constraints resulted from the "significant" capital required to develop its projects.

----------

By Elizabeth Winter, Alliance News senior markets reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
14 Dec 2021 18:01

TRADING UPDATES: Cohort interim loss widens, Yourgene loss narrows

TRADING UPDATES: Cohort interim loss widens, Yourgene loss narrows

Read more
7 Dec 2021 14:42

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
18 Nov 2021 15:24

TRADING UPDATES: Henry Boot wins York deal; Sativa and Superdrug team

TRADING UPDATES: Henry Boot wins York deal; Sativa and Superdrug team

Read more
26 Oct 2021 17:39

TRADING UPDATES: East Star makes buy; Kromek wins USD17 million deal

TRADING UPDATES: East Star makes buy; Kromek wins USD17 million deal

Read more
26 Oct 2021 10:20

Yourgene Health interim revenues grow 'strongly'

(Sharecast News) - Molecular diagnostics group Yourgene Health said on Tuesday that interim revenues grew strongly to £17.5m, more than double the £8.2m recorded in the prior year and ahead of previous guidance of £15.0m.

Read more
28 Sep 2021 17:21

IN BRIEF: Yourgene Health expects interim revenue to nearly double

IN BRIEF: Yourgene Health expects interim revenue to nearly double

Read more
21 Sep 2021 16:05

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
21 Sep 2021 16:04

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
1 Sep 2021 14:33

TRADING UPDATES: Trifast buys in US; Eckoh trading meets expectations

TRADING UPDATES: Trifast buys in US; Eckoh trading meets expectations

Read more
19 Aug 2021 12:50

TRADING UPDATES: Resolute books hefty impairments; tinyBuild buys

TRADING UPDATES: Resolute books hefty impairments; tinyBuild buys

Read more
11 Aug 2021 17:29

EARNINGS UPDATES: Woodbois reports narrowed loss; Goodwin profit rises

EARNINGS UPDATES: Woodbois reports narrowed loss; Goodwin profit rises

Read more
21 Jun 2021 21:26

IN BRIEF: Yourgene Health secures agreement for Ranger technology

IN BRIEF: Yourgene Health secures agreement for Ranger technology

Read more
18 Jun 2021 13:23

TRADING UPDATES: DP Poland sales improve; Braveheart swings to profit

TRADING UPDATES: DP Poland sales improve; Braveheart swings to profit

Read more
18 Jun 2021 09:17

Yourgene awarded supply contract with NHS Wales

(Sharecast News) - Molecular diagnostics group Yourgene Health has secured a contract to supply its Elucigene DPYD testing kits to NHS Wales.

Read more
9 Jun 2021 14:09

IN BRIEF: Yourgene Health signs deal with US precision medicine firm

IN BRIEF: Yourgene Health signs deal with US precision medicine firm

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.